CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Noninvasive Peripheral Nerve Stimulation (NPNS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04698343
NCT04698343N/ACompleted
CompareCT.gov

Exploratory Study Assessing the Response of Restless Legs Syndrome (RLS) Patients to Non-invasive Peripheral Nerve Stimulation (NPNS) During Opioid Medication Reduction

Noctrix Health, Inc.·interventional·Posted Jan 6, 2021·Updated Sep 19, 2024

In Brief

A clinical study evaluating Noninvasive Peripheral Nerve Stimulation (NPNS) for Restless Legs Syndrome. Completed, enrolled 21 participants across 2 sites.

Detailed Summary

Prospective open-label single-arm feasibility study assessing the tolerability of opioid medication reduction in conjunction with noninvasive peripheral nerve stimulation (NPNS) for patients taking prescription opioids to treat moderate-severe primary RLS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRestless Legs Syndrome
CountriesUnited States
CollaboratorsNational Institute of Neurological Disorders and Stroke (NINDS)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJan 6, 2021
Enrollment StartApr 6, 2021
Primary CompletionFeb 27, 2023
Study CompletionMar 28, 2023
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 5.5 years ago

Interventions

Noninvasive Peripheral Nerve Stimulation (NPNS)device

NPNS device programmed to deliver active stimulation.